CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-26 | Lichter Jay Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-26 | McNulty Alana B. Director | Grant or award | +2,500 | 2,500 | ||
| 2024-06-26 | McNulty Alana B. Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-26 | Kung Winston Director | Grant or award | +2,500 | 2,500 | ||
| 2024-06-26 | Kung Winston Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-26 | Gujrathi Sheila Director | Grant or award | +2,500 | 110,528 | ||
| 2024-06-26 | Gujrathi Sheila Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-26 | Barrett Ronald W Director | Grant or award | +2,500 | 2,500 | ||
| 2024-06-26 | Barrett Ronald W Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-26 | Simson Jake Director | Grant or award | +2,500 | 2,500 | ||
| 2024-06-26 | Simson Jake Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-26 | CAPPS VICKIE L Director | Grant or award | +2,500 | 68,043 | ||
| 2024-06-26 | CAPPS VICKIE L Director | Grant or award · Stock Option (right to buy) | +8,350 | 8,350 | ||
| 2024-06-03 | Lichter Jay Director | Sale | −677,279 | $54.75 | $37.1M | 3,271,216 |
| 2024-06-03 | Lichter Jay Director | Sale | −131,196 | $54.75 | $7.2M | 633,673 |
| 2024-06-03 | Lichter Jay Director | Sale | −691,525 | $54.75 | $37.9M | 3,340,018 |
| 2024-06-03 | Reardon Tighe Acting Chief Financial Officer | Sale | −131,196 | $54.75 | $7.2M | 633,673 |
| 2024-06-03 | Reardon Tighe Acting Chief Financial Officer | Sale | −691,525 | $54.75 | $37.9M | 3,340,018 |
| 2024-06-03 | Avalon Ventures XI, L.P. 10% owner | Sale | −677,279 | $54.75 | $37.1M | 3,271,216 |
| 2024-06-03 | Avalon Ventures XI, L.P. 10% owner | Sale | −131,196 | $54.75 | $7.2M | 633,673 |
Page 13 of 15 · 294 trades